DSIP Research Highlights Commonly evaluated in neuropeptide and neuro-signaling research Studied for synaptic, stress-response, or neurotrophic pathway activity Used in controlled in vitro and laboratory research models Helpful for comparing nervous-system-related peptide mechanisms DSIP Research Background DSIP appears in research discussions related to sleep-cycle, stress-response, and neuroendocrine pathway research

Dosing Protocols in Research Most gene expression studies used GHK-Cu at concentrations equivalent to: Subcutaneous injection: 12 mg/day (common biohacking protocol) Topical application: 15% concentration creams/serums (skin-focused gene effects) In vitro concentrations: 10100 nM range in cell studies For subcutaneous use, peptide community protocols typically run: Dose: 12 mg/day Cycle: 3090 days on, 30 days off Injection site: Subcutaneous, rotating sites Common stack: GHK-Cu + BPC-157 (synergistic tissue repair), GHK-Cu + MOTS-C (longevity stack), GHK-Cu + Retatrutide (body recomposition with connective tissue support) Topical use is effective for skin-specific outcomes
Participants took 550 mg of berberine twice daily for 60 days
However, upon arrival, it should be immediately transferred to a refrigerator for optimal long-term stability.